Lumakras showed a median overall survival of 12.5 months in previously treated NSCLC patients

Iksuda will use the funds to support the progression of IKS03 into first-in-human Phase I clinical trials

JCVI will advise on whether this younger age group will be vaccinated routinely

Mining the world’s most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or […]

Fueled by COVID drug manufacturing revenues, CDMO Jubilant HollisterStier invests in upgrades, expansion kdunleavy Fri, 06/04/2021 – 15:51

Novo Nordisk’s semaglutide set to tackle obesity with hotly-anticipated FDA green light fkansteiner Fri, 06/04/2021 – 14:12

After breakout year, Moderna on track to generate $15B+ in 2022 thanks to more demand, higher prices: analysts […]

AbbVie exec details upbeat plan for Rinvoq, Skyrizi as Humira copycats near: analyst esagonowsky Fri, 06/04/2021 – 10:02

AstraZeneca shuffles leadership ahead of megadeal close, tapping an Alexion CEO and bringing up a new CFO fkansteiner […]

Pharma delivers: New campaign celebrates pharma distribution companies’ role during pandemic sharon.coey Fri, 06/04/2021 – 08:41